Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?

J Hepatol. 2016 Nov;65(5):1068-1069. doi: 10.1016/j.jhep.2016.07.029. Epub 2016 Jul 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents
  • Carcinoma, Hepatocellular*
  • Hepacivirus
  • Hepatitis C
  • Hepatitis C, Chronic
  • Humans
  • Incidence
  • Liver Neoplasms*

Substances

  • Antiviral Agents